Back to search

Article

Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells

2023-01-30

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Despite recent advances in locoregional, systemic, and novel checkpoint inhibitor treatment, hepatocellular carcinoma (HCC) is still associated with poor prognosis. The feasibility of potentially curative liver resection (LR) and transplantation (LT) is limited by underlying liver disease and a shortage of organ donors. Especially after LR, we are dealing with h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5636eebf-fab9-58ad-acf5-e56415324700
DOI
10.21203/rs.3.rs-2495698/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cellsDOI 10.21203/rs.3.rs-2495698/v1
Select a neighboring publication to make it the new centre.